168 related articles for article (PubMed ID: 37575337)
1. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An
Solan ME; Lavado R
Curr Res Toxicol; 2023; 5():100116. PubMed ID: 37575337
[TBL] [Abstract][Full Text] [Related]
2. The impact of legacy and novel perfluoroalkyl substances on human cytochrome P450: An in vitro study on the inhibitory potential and underlying mechanisms.
Amstutz VH; Cengo A; Sijm DTHM; Vrolijk MF
Toxicology; 2022 Feb; 468():153116. PubMed ID: 35121066
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on toxicologically relevant gene expression profiles in a liver-on-a-chip model.
Solan ME; Schackmuth B; Bruce ED; Pradhan S; Sayes CM; Lavado R
Environ Pollut; 2023 Nov; 337():122610. PubMed ID: 37742859
[TBL] [Abstract][Full Text] [Related]
4. Short-chain per- and polyfluoralkyl substances (PFAS) effects on oxidative stress biomarkers in human liver, kidney, muscle, and microglia cell lines.
Solan ME; Koperski CP; Senthilkumar S; Lavado R
Environ Res; 2023 Apr; 223():115424. PubMed ID: 36740157
[TBL] [Abstract][Full Text] [Related]
5. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
[TBL] [Abstract][Full Text] [Related]
6. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
[TBL] [Abstract][Full Text] [Related]
7. Per- and polyfluoroalkyl substances (PFAS) augment adipogenesis and shift the proteome in murine 3T3-L1 adipocytes.
Modaresi SMS; Wei W; Emily M; DaSilva NA; Slitt AL
Toxicology; 2022 Jan; 465():153044. PubMed ID: 34800597
[TBL] [Abstract][Full Text] [Related]
8. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey.
Calafat AM; Kato K; Hubbard K; Jia T; Botelho JC; Wong LY
Environ Int; 2019 Oct; 131():105048. PubMed ID: 31376596
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Transcriptome Comparative In Silico Analysis Reveals Similar Pathways and Targets Altered by Legacy and Alternative Per- and Polyfluoroalkyl Substances in Mice.
Robarts DR; Dai J; Lau C; Apte U; Corton JC
Toxics; 2023 Nov; 11(12):. PubMed ID: 38133364
[TBL] [Abstract][Full Text] [Related]
10. Effects of perfluoroalkyl substances (PFASs) and benzo[a]pyrene (BaP) co-exposure on phase I biotransformation in rainbow trout (Oncorhynchus mykiss).
Solan ME; Franco ME; Lavado R
Fish Physiol Biochem; 2022 Aug; 48(4):925-935. PubMed ID: 35752723
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
Ojo AF; Peng C; Ng JC
Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
[TBL] [Abstract][Full Text] [Related]
12. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Developmental Toxicity, Developmental Neurotoxicity, and Tissue Dose in Zebrafish Exposed to GenX and Other PFAS.
Gaballah S; Swank A; Sobus JR; Howey XM; Schmid J; Catron T; McCord J; Hines E; Strynar M; Tal T
Environ Health Perspect; 2020 Apr; 128(4):47005. PubMed ID: 32271623
[TBL] [Abstract][Full Text] [Related]
14. Contamination of groundwater with per- and polyfluoroalkyl substances (PFAS) from legacy landfills in an urban re-development precinct.
Hepburn E; Madden C; Szabo D; Coggan TL; Clarke B; Currell M
Environ Pollut; 2019 May; 248():101-113. PubMed ID: 30784829
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of potential herb-drug interactions based on the effect of Suxiao Jiuxin Pill on CYP450 enzymes and transporters.
Qiang T; Li Y; Wang K; Lin W; Niu Z; Wang D; Wang X
J Ethnopharmacol; 2021 Nov; 280():114408. PubMed ID: 34252529
[TBL] [Abstract][Full Text] [Related]
16. Serum Half-Lives for Short- and Long-Chain Perfluoroalkyl Acids after Ceasing Exposure from Drinking Water Contaminated by Firefighting Foam.
Xu Y; Fletcher T; Pineda D; Lindh CH; Nilsson C; Glynn A; Vogs C; Norström K; Lilja K; Jakobsson K; Li Y
Environ Health Perspect; 2020 Jul; 128(7):77004. PubMed ID: 32648786
[TBL] [Abstract][Full Text] [Related]
17. Behavioural effects and bioconcentration of per- and polyfluoroalkyl substances (PFASs) in zebrafish (Danio rerio) embryos.
Menger F; Pohl J; Ahrens L; Carlsson G; Örn S
Chemosphere; 2020 Apr; 245():125573. PubMed ID: 31877453
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran.
Paris BL; Ogilvie BW; Scheinkoenig JA; Ndikum-Moffor F; Gibson R; Parkinson A
Drug Metab Dispos; 2009 Oct; 37(10):2045-54. PubMed ID: 19608694
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
[TBL] [Abstract][Full Text] [Related]
20. Biomonitoring of emerging contaminants, perfluoroalkyl and polyfluoroalkyl substances (PFAS), in New Jersey adults in 2016-2018.
Yu CH; Riker CD; Lu SE; Fan ZT
Int J Hyg Environ Health; 2020 Jan; 223(1):34-44. PubMed ID: 31679856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
